Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMaintaining weight loss after Mounjaro means combining the habits you built during treatment with a plan for what comes next. Tirzepatide suppresses appetite while you take it; once you stop, that suppression lifts. Research and clinical experience both point to the same answer: the people who keep weight off are those who use the treatment period to lock in sustainable behaviour change, not just to eat less. As a prescription-only medicine, Mounjaro requires clinical assessment and prescriber oversight at every stage — including decisions about when and how to stop — so this guide is a starting point, not a substitute for that conversation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works partly by slowing gastric emptying and reducing appetite, which gives you a quieter relationship with food for as long as you take it. The critical thing to understand is that this window is finite. Studies following people after they stopped GLP-1 treatment showed that a significant proportion of weight lost was regained within a year without structured support, not because of a character flaw, but because the biology that drove the original weight gain re-asserts itself.
That makes the treatment period itself the most important time to act. Use lower appetite to practise portion sizes you can sustain. Learn what hunger actually feels like at a comfortable level. Build a plate structure (roughly half vegetables, a generous protein portion, modest carbohydrates) that becomes automatic. You are, in effect, rehearsing for the maintenance phase while Mounjaro is still in the room with you. Our page on maintaining weight loss after tirzepatide covers the broader evidence base if you want to read further.
None of this needs to be perfect during treatment. It needs to be practised. That distinction matters, perfectionism tends to collapse; practiced habits bend and recover.
Weight loss on Mounjaro includes some loss of lean muscle mass alongside fat, as it does with any significant calorie deficit. Muscle is metabolically active tissue: less of it means a lower resting energy expenditure, which makes maintaining a reduced weight harder over time. This is why the composition of what you lose matters, not only the total.
Two things slow muscle loss and help rebuild it: adequate dietary protein and resistance exercise. On protein, the current guidance for people trying to preserve lean mass during weight loss generally points toward at least 1.2–1.6 g per kilogram of body weight daily, though your prescriber or a registered dietitian should advise on your specific target, since factors like kidney function matter. On exercise, strength or resistance work two to three times a week is the most evidence-supported approach; it does not require a gym. Bodyweight exercises, resistance bands, or carrying loaded shopping bags up stairs all count.
The factors that affect how much weight you lose on Mounjaro include baseline muscle mass and activity level, which is another reason building these habits during treatment pays dividends afterwards.
Weight fluctuates day to day with hydration, hormones and what you ate the night before. A single bad weigh-in is not a trend. A consistent upward drift over three to four weeks is a signal worth acting on, and acting on it early, when the gap is small, is far easier than addressing a larger regain later.
A simple weekly weigh-in, same morning, same conditions, recorded somewhere you can glance at it, is enough for most people. Some find it useful to keep a rough food diary for a month or two after stopping treatment, not as a permanent arrangement, but as a recalibration exercise to see where portion sizes have crept back up. Keeping your pen in the fridge door during treatment is one thing; after stopping, that same habit of a weekly check-in can serve a similar anchoring function.
If you notice early regain and are concerned, the right first step is to speak to your prescriber. There is an open clinical question about whether continuing Mounjaro at the lowest effective dose to maintain weight is appropriate for some individuals, and that is a decision requiring clinical review, not a self-managed one. The timeline of how Mounjaro works may also help set realistic expectations about what changes to expect during and after treatment.
The biggest predictor of successful weight maintenance after any pharmacological treatment is whether the stop was planned or abrupt. Stopping Mounjaro suddenly, without a transition plan, removes the appetite suppression quickly and leaves a gap where structure needs to be. This is not a reason to stay on treatment indefinitely, it is a reason to plan the off-ramp carefully with clinical support.
Questions worth discussing with your prescriber include: Is this the right time to stop, given your current weight trajectory? Should you step down the dose gradually rather than stopping at the highest tolerated dose? What monitoring will you have in place for the first three to six months after stopping? Is there any clinical reason to consider a longer treatment course?
For a fuller look at the specific evidence on what happens after stopping, our page on maintaining weight loss after stopping Mounjaro goes into detail. And if questions arise about dosing intervals, the clinical picture around less-frequent dosing for maintenance is worth reading too, with the caveat that any change to your schedule is a prescriber decision, not a self-directed one.
The long-term maintenance picture after tirzepatide treatment is an active area of clinical interest. NHS guidance consistently recommends that weight-loss medicines be used alongside dietary support and increased physical activity, not as a standalone solution, the NHS England guidance on weight-management injections and the NHS tirzepatide patient information page both make this clear. If you have questions about treatment options or whether continued prescribing is right for you, a conversation with a clinical team is the right starting point. You can start your free consultation with our prescribers to discuss where you are in your treatment journey.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.